Format

Send to

Choose Destination
See comment in PubMed Commons below
Int Psychogeriatr. 2013 Jul;25(7):1199-201. doi: 10.1017/S1041610212002037. Epub 2012 Nov 30.

A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.

Author information

  • 1Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan. t.nagata@jikei.ac.jp

Abstract

A 48-year-old woman with Parkinson disease (PD) suffered from auditory hallucinations (AH). We had treated her with a reduction in antiparkinsonian agents and the use of atypical antipsychotic agents. However, her symptoms did not improve, and her extrapyramidal symptoms (EPS) worsened. To lessen her depressive symptoms, treatment with a new-generation antidepressant, mirtazapine (MRZ), was commenced. The patient's AH gradually decreased with no worsening of EPS, and the AH disappeared 4 weeks after the commencement of treatment with MRZ. The present case suggests the effectiveness of MRZ for the treatment of refractory AHs in patients with PD.

PMID:
23195073
DOI:
10.1017/S1041610212002037
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press
    Loading ...
    Support Center